Meknes: Malaysia’s DXN Breaks Ground on Its Spirulina and Ganoderma Plant

Malaysian group DXN Holdings announced on October 23 that work has begun on its first plant in North Africa, in Meknes, on an 80,765-square-meter site in the Agropolis industrial park. The project has received the approval of the Moroccan authorities and its building permit.

Aerial view of white and blue industrial buildings at the foot of wooded hills, with a large parking lot in the foreground.
DXN’s headquarters and facilities in the Malaysian state of Kedah. Photo: MIDA.

The unit will produce supplements based on spirulina and ganoderma, a mushroom Asia knows as lingzhi, and is expected to create some two hundred and fifty jobs.

The memorandum of understanding of May 27, 2024, concluded by its subsidiary Dexin Morocco with the ministries of Industry and Investment, put the investment at about 161 million dirhams.

DXN is still negotiating the definitive investment agreement with the government, which will set the subsidies and incentives granted to the project. Only that signature will create binding obligations between the parties.

The group, which aims to take its network from 14 to 21 factories, intends to make Meknes a production hub for North Africa and Europe, alongside its site in the Middle East.

Photo: Pedro from Maia (Porto), Portugal, CC BY 2.0.

References:

DXN Holdings Bhd. (Bursa Malaysia) - Memorandum of Understanding entered into between the Ministry of Industry and Trade, the Ministry of Investment, Convergence and Evaluation of Public Policies and Dexin Morocco SA

New Straits Times - DXN breaks ground on its first North African plant in Morocco

Business Today - DXN Expands Into North Africa With First Manufacturing Plant In Morocco